Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Cell Count × 1 year × Clear all

Sponsor

Conditions

Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Recurrence 1 Peritoneal Neoplasms 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Ovarian Diseases 1 Neoplasms, Glandular and Epithelial 1 Neoplasms 1 Immunologic Deficiency Syndromes 1 Glioblastoma 1 Genital Neoplasms, Female 1 Fallopian Tube Neoplasms 1 Epstein-Barr Virus Infections 1 Cytomegalovirus Infections 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma in Situ 1 Adenoviridae Infections 1 Abdominal Neoplasms 1

Interventions

Cyclophosphamide 58 Rituximab 47 fludarabine 38 fludarabine phosphate 25 obinutuzumab 17 venetoclax 16 Lenalidomide 16 ibrutinib 15 Etoposide 14 Prednisone 13 pirtobrutinib 12 Whole-Body Irradiation 12 Mycophenolic Acid 11 Melphalan 11 Bendamustine Hydrochloride 11 Tacrolimus 10 Specimen Handling 10 Filgrastim 10 Doxorubicin 10 Biopsy 10 Vincristine 9 Magnetic Resonance Spectroscopy 9 Granulocyte Colony-Stimulating Factor 9 pembrolizumab 8 Stem Cell Transplantation 8 Peripheral Blood Stem Cell Transplantation 8 Nivolumab 8 Gemcitabine 8 Cytarabine 8 tocilizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡